Table 5.
Involvement of SNHG16 in cancer prognosis
| Cancer type | Prognostic indicator | Associated clinical features | Ref. |
|---|---|---|---|
| Bladder cancer | OS | tumor stage, histological grade, lymph node metastasis | [23, 25] |
| Cervical cancer | OS | tumor size, tumor differentiation, lymph node metastasis, FIGO stage | [28, 29] |
| Colorectal Cancer | OS | – | [32] |
| Endometrial carcinoma | OS, recurrence free survival | – | [34] |
| Esophageal squamous cell carcinoma | OS | tumor stage, clinical stage, lymph nodes metastasis | [36] |
| Gastric Cancer | OS | tumor size, tumor differentiation, TNM stage, lymph node metastasis | [37, 38] |
| Glioma | OS, PFS | tumor size, WHO grade | [41] |
| Hepatocellular carcinoma | OS, PFS | tumor size, TNM stage | [45, 46, 49, 50] |
| Neuroblastoma | OS, event free survival | – | [20, 52] |
| Non small cell lung cancer | OS, DFS | tumor size, TNM stage, lymph node metastasis | [53] |
| Osteosarcoma | OS | – | [57, 59] |
| Ovarian cancer | OS | clinical stage, distance metastasis | [60] |
| Pancreatic cancer | OS | TNM stage, tumor differentiation, distant metastasis | [61] |